The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of AdAPT-001 on checkpoint inhibitor resistance in solid tumors.
 
Anthony Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst)
Travel, Accommodations, Expenses - Genentech
 
Christina Roland
Consulting or Advisory Role - Lumanity
 
Tony Reid
Employment - Epicentrx
Leadership - Epicentrx
Stock and Other Ownership Interests - Epicentrx
Patents, Royalties, Other Intellectual Property - Epicentrx licensed patented technology
 
Christopher Larson
Employment - EpicentRx
Patents, Royalties, Other Intellectual Property - EpicentRx
 
Nacer Abrouk
Consulting or Advisory Role - EpicentRx
 
Bryan Oronsky
Employment - EpicentRx
Leadership - EpicentRx; EpicentRx (I)
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor of several technologies under EpicentRx. Inc.
 
Erica Burbano
Employment - EpicentRx
 
Jeannie Williams
Employment - EpicentRx
 
Meaghan Stirn
Employment - EpicentRx
 
Lucy Kennedy
Research Funding - EpicentRx; IDEAYA Biosciences; Regeneron
 
Vinod Ravi
Stock and Other Ownership Interests - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma
Honoraria - UpToDate
Consulting or Advisory Role - AADi; Daiichi Sankyo; Daiichi Sankyo; Deciphera; Deciphera; Gerson Lehrman Group; Guidepoint Inc
Research Funding - AADi (Inst); Athenex (Inst); Deciphera (Inst); Ikena Oncology (Inst); Ikena Oncology (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo